[PDF][PDF] Adalimumab dose tapering in psoriasis: predictive factors for maintenance of complete clearance.
K Hansel, L Bianchi, F Lanza, V Bini… - Acta Dermato …, 2017 - research.unipg.it
Study design After one year of maintained PASI-100, the between-dose intervals were
progressively extended, stepping up 3–4 days each month, up to a 21-or 28-day interval …
progressively extended, stepping up 3–4 days each month, up to a 21-or 28-day interval …
[引用][C] Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance
K Hansel, L Bianchi, F Lanza… - Acta Dermato …, 2017 - medicaljournalssweden.se
Psoriasis can be managed successfully with long-term biologics. Real-life clinical practice
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance
K Hansel, L Bianchi, F Lanza… - Acta dermato …, 2017 - pubmed.ncbi.nlm.nih.gov
Psoriasis can be managed successfully with long-term biologics. Real-life clinical practice
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
[PDF][PDF] Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance
K HANSEL, L BIANCHI, F LANZA, V BINI… - Acta Derm …, 2017 - researchgate.net
Study design After one year of maintained PASI-100, the between-dose intervals were
progressively extended, stepping up 3–4 days each month, up to a 21-or 28-day interval …
progressively extended, stepping up 3–4 days each month, up to a 21-or 28-day interval …
[PDF][PDF] Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance
K HANSEL, L BIANCHI, F LANZA… - Acta Derm …, 2017 - pdfs.semanticscholar.org
Study design After one year of maintained PASI-100, the between-dose intervals were
progressively extended, stepping up 3–4 days each month, up to a 21-or 28-day interval …
progressively extended, stepping up 3–4 days each month, up to a 21-or 28-day interval …
Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance.
K Hansel, L Bianchi, F Lanza, V Bini… - Acta Dermato …, 2017 - europepmc.org
Psoriasis can be managed successfully with long-term biologics. Real-life clinical practice
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance
K Hansel, L Bianchi, F Lanza, V Bini… - ACTA DERMATO …, 2017 - research.unipg.it
Psoriasis can be managed successfully with long-term biologics. Real-life clinical practice
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
Adalimumab Dose Tapering in Psoriasis: Predictive Factors for Maintenance of Complete Clearance.
K HANSEL, L BIANCHI, F LANZA… - Acta Dermato …, 2017 - search.ebscohost.com
Psoriasis can be managed successfully with long-term biologics. Real-life clinical practice
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …
may require dose tapering as a therapeutic option to reduce the risk of drug-exposure and to …